Glucagon-like peptide-1 (736) amide (GLP-1) enhances insulin stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action
The GTT indicated significantly lower blood glucose AUC in Donor+Cas9 treated mice compared to Saline and Donor groups at 8, 16, and 24 weeks post-injection, with levels comparable to non-treated mice fed with normal fat diet (Normal Diet) at matching time points
The claim that pH incompatibility would cause degradation is not supported by the quantitative stability data
[DOI] [PMC free article] [PubMed] [Google Scholar] 118.Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US
[DOI] [PubMed] [Google Scholar] 94.de Andrade Kratz C., de Salles Painelli V., de Andrade Nemezio K.M., da Silva R.P., Franchini E., Zagatto A.M., Gualano B., Artioli G.G